The recent article by Dreborg et al1 concluded that Emerade, defined as a low-pressure epinephrine auto-injector, has no risk of intraosseous injection in children and a low risk of subcutaneous injection in adolescents and adults. However, assumptions leading to these conclusions could be incorrect.
https://ift.tt/2JoOc6T
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου